{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:00:45Z","timestamp":1792458045648,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-024-00829-4","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:36:19Z","timestamp":1738665379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intratympanic N-acetylcysteine in the prevention of cisplatin-induced ototoxicity: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohamed","family":"Tawalbeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rewan M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taif","family":"Al-Saraireh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Khreesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baeth Al","family":"Rawashdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"829_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","volume":"193","author":"D Dickey","year":"2004","unstructured":"Dickey D, Muldoon L, Kraemer D, Neuwelt A. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res. 2004;193:25\u201330.","journal-title":"Hear Res"},{"key":"829_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/00129492-200411000-00009","volume":"25","author":"C Won-Taek","year":"2004","unstructured":"Won-Taek C, Chinosornvatana N, Kay W. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol. 2004;25:910\u201315.","journal-title":"Otol Neurotol"},{"key":"829_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0378-5955(90)90046-R","volume":"50","author":"MA Gratton","year":"1990","unstructured":"Gratton MA. The interaction of cisplatin and noise on the peripheral auditory system. Hear Res. 1990;50:211\u201324.","journal-title":"Hear Res"},{"key":"829_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.7326\/0003-4819-86-6-803","volume":"86","author":"M Rozencweig","year":"1977","unstructured":"Rozencweig M, von Hoff DD, Slavik M, Muggia FM. Cisdiamminedichloroplatinum (II): a new anticancer drug. Ann Intern Med. 1977;86:803\u201312.","journal-title":"Ann Intern Med"},{"key":"829_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/bmj.1.6179.1689","volume":"1","author":"CJ Williams","year":"1979","unstructured":"Williams CJ, Whitehouse JM. Cis-platinum: a new anticancer agent. Br Med J. 1979;1:1691\u201398.","journal-title":"Br Med J"},{"key":"829_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/00129492-200411000-00009","volume":"25","author":"WT Choe","year":"2004","unstructured":"Choe WT, Chinosornvatana N, Chang KW. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol. 2004;25:910\u20135.","journal-title":"Otol Neurotol"},{"key":"829_CR7","doi-asserted-by":"crossref","unstructured":"Page MK. Bossuyt, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","DOI":"10.31222\/osf.io\/v7gm2"},{"key":"829_CR8","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. editors."},{"key":"829_CR9","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web, and mobile app for systematic reviews."},{"key":"829_CR10","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range."},{"key":"829_CR11","unstructured":"Egger M, Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test."},{"key":"829_CR12","unstructured":"Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity."},{"key":"829_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/archotol.1994.01880290051009","volume":"120","author":"BW Blakley","year":"1994","unstructured":"Blakley BW, Gupta AK, Myers SF, Schwan S. Risk factors for ototoxicity due to cisplatin. Arch Otolaryngol Head Neck Surg. 1994;120:541\u20136.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"829_CR14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1017\/S0022215100091374","volume":"95","author":"L Rybak","year":"1981","unstructured":"Rybak L. Cis-platinum associated hearing loss. J Laryngol Otol. 1981;95:745\u20137.","journal-title":"J Laryngol Otol"},{"key":"829_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0277-5379(83)90398-X","volume":"19","author":"J Vermorken","year":"1983","unstructured":"Vermorken J. Ototoxicity of cisdiamminedichloroplatinum (II): influence of dose schedule and mode of administration. Eur J Cancer Clin Oncol. 1983;19:52\u20138.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"829_CR16","doi-asserted-by":"publisher","first-page":"13422","DOI":"10.1074\/jbc.271.23.13422","volume":"271","author":"R Pinkus","year":"1996","unstructured":"Pinkus R, Weiner LM, Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kB, and glutathione S-transferase gene expression. J Biol Chem. 1996;271:13422\u20139.","journal-title":"J Biol Chem"},{"key":"829_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2004.09.025","volume":"38","author":"L Grinberg","year":"2005","unstructured":"Grinberg L, Fibach E, Amer J, Atlas D. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic Biol Med. 2005;38:136\u201345.","journal-title":"Free Radic Biol Med"},{"key":"829_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.heares.2004.02.005","volume":"2","author":"M Duan","year":"2004","unstructured":"Duan M, Qiu J, Laurell G, Olofsson A, Counter SA, Borg E. Dose and time-dependent protection of the antioxidant N-L- acetylcysteine against impulse noise trauma. Hear Res. 2004;2:1\u20139.","journal-title":"Hear Res"},{"key":"829_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1200\/JCO.2006.10.077","volume":"24","author":"JM Rademaker-Lakhai","year":"2006","unstructured":"Rademaker-Lakhai JM, Rademaker-Lakhai JM, Crul M, Baas P, Beijnen JH, Simis YJ, et al. Relationship between cisplatin administration and the development of ototoxicity. J Clin Oncol. 2006;24:918\u201324.","journal-title":"J Clin Oncol"},{"key":"829_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.heares.2009.08.010","volume":"259","author":"H Eastwood","year":"2010","unstructured":"Eastwood H, Pinder D, James D, Chang A, Galloway S, Richardson R, et al. Permanent and transient effects of locally delivered n-acetyl cysteine in a guinea pig model of cochlear implantation. Hear Res. 2010;259:24\u201330.","journal-title":"Hear Res"},{"key":"829_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"KR Atkuri","year":"2007","unstructured":"Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-acetylcysteine-A safe antidote for cysteine\/glutathione deficiency. Curr Opin Pharmacol. 2007;7:355\u20139.","journal-title":"Curr Opin Pharmacol"},{"key":"829_CR22","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/MOO.0b013e32830e20db","volume":"16","author":"DA Borkholder","year":"2008","unstructured":"Borkholder DA. State-of-the-art mechanisms of intra-cochlear drug delivery. Curr Opin Otolaryngol Head Neck Surg. 2008;16:472\u20137.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"829_CR23","unstructured":"Hans M, Borchgrevink P, Hallmo, Iain WS, Mair. Extended High-Frequency Hearing Loss from Noise Exposure, 5th International Symposium of Effects of Noise on Hearing, State University of New York, Plattsburgh, NY 12901, January 1996."},{"key":"829_CR24","unstructured":"Mario A, Ruggero NC, Rich L, Robles, Recio A. The Effects of Acoustic Trauma, Other Cochlear Injury, and Death on Basilar-Membrane Responses to Sound, 5th International Symposium of Effects of Noise on Hearing, State University of New York, Plattsburgh, NY 12901, January 1996."},{"key":"829_CR25","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/1097-0142(19851015)56:8<1934::AID-CNCR2820560807>3.0.CO;2-F","volume":"56","author":"S Schaefer","year":"1985","unstructured":"Schaefer S, Post JD, Close LG, Wright CG. Ototoxicity of low and moderate dose cisplatin. Cancer. 1985;56:1934\u20139.","journal-title":"Cancer"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-024-00829-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:36:24Z","timestamp":1738665384000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-024-00829-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1186\/s40360-024-00829-4","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This research doesn\u2019t involve the direct recruiting of human participants or the acquisition of new data; therefore, it generally does not necessitate ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed the results, approved the final version of the manuscript, and agreed to publish it.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}